Genomic Profiling of a Phase III Clinical Trial of Interferon Versus Hydroxyurea in MPN Patients Reveals Mutation-Specific and Treatment-Specific Patterns of Response

Trine Alma Knudsen, Vibe Skov, Lillian Werner, William Duke, Christopher J. Gibson, Anwesha Nag, Aaron R. Thorner, Bruce Wollison, Dennis Lund Hansen, Thomas Stauffer Larsen, Christina Ellervik, Daniel El Fassi, Karin de Stricker, Lukas Frans Ocias, Mette Brabrand, Ole Weiss Bjerrum, Ulrik Malthe Overgaard, Mikael Frederiksen, Thomas Kielsgaard Kristensen, Torben A KruseMads Thomassen, Hans Torben Mourits-Andersen, Marianne Tang Severinsen, Stentoft Jesper, Jørn Starklint, Peter Møller, Donna S. Neuberg, Lasse Kjær, Hans Carl Hasselbalch, R Coleman Lindsley, Ann Mullally

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
Article number4202
JournalBlood
Volume134
Issue numberSupplement 1
ISSN0006-4971
DOIs
Publication statusPublished - 13. Nov 2019
EventAmerican Society of Hematology: 61st Annual Meeting (ASH) - Orlando, United States
Duration: 7. Dec 201910. Dec 2019

Conference

ConferenceAmerican Society of Hematology: 61st Annual Meeting (ASH)
CountryUnited States
CityOrlando
Period07/12/201910/12/2019

Cite this

Knudsen, T. A., Skov, V., Werner, L., Duke, W., Gibson, C. J., Nag, A., Thorner, A. R., Wollison, B., Lund Hansen, D., Larsen, T. S., Ellervik, C., El Fassi, D., de Stricker, K., Ocias, L. F., Brabrand, M., Weiss Bjerrum, O., Overgaard, U. M., Frederiksen, M., Kielsgaard Kristensen, T., ... Mullally, A. (2019). Genomic Profiling of a Phase III Clinical Trial of Interferon Versus Hydroxyurea in MPN Patients Reveals Mutation-Specific and Treatment-Specific Patterns of Response. Blood, 134(Supplement 1), [4202]. https://doi.org/10.1182/blood-2019-126164